{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:31:51Z","timestamp":1771561911954,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,19]]},"DOI":"10.7759\/cureus.103935","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:42:52Z","timestamp":1771558972000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Acanthamoeba Keratitis Using 0.08% Polyhexamethylene Biguanide Monotherapy: A Report of a Case in Latin America"],"prefix":"10.7759","author":[{"given":"Astrid","family":"Pabon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivanna Agustina","family":"Lavagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Daniel","family":"Paredes Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha Vanessa","family":"Duran Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norka","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67803","article-title":"A comprehensive review on Acanthamoeba keratitis: An overview of epidemiology, risk factors, and therapeutic strategies","volume":"16","author":"Garg D","year":"2024","unstructured":"Garg D, Daigavane S. A comprehensive review on Acanthamoeba keratitis: An overview of epidemiology, risk factors, and therapeutic strategies. Cureus. 2024, 16:e67803. 10.7759\/cureus.67803","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2022.04.003","article-title":"Advances in the management of Acanthamoeba keratitis: A review of the literature and synthesized algorithmic approach","volume":"25","author":"Kaufman AR","year":"2022","unstructured":"Kaufman AR, Tu EY. Advances in the management of Acanthamoeba keratitis: A review of the literature and synthesized algorithmic approach. Ocul Surf. 2022, 25:26-36. 10.1016\/j.jtos.2022.04.003","journal-title":"Ocul Surf"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14792","article-title":"Delayed diagnoses of Acanthamoeba keratitis at a tertiary care medical centre","volume":"99","author":"Shah YS","year":"2021","unstructured":"Shah YS, Stroh IG, Zafar S, et al.. Delayed diagnoses of Acanthamoeba keratitis at a tertiary care medical centre. Acta Ophthalmol. 2021, 99:916-21. 10.1111\/aos.14792","journal-title":"Acta Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10030323","article-title":"Acanthamoeba keratitis, pathology, diagnosis and treatment","volume":"10","author":"Fanselow N","year":"2021","unstructured":"Fanselow N, Sirajuddin N, Yin XT, Huang AJ, Stuart PM. Acanthamoeba keratitis, pathology, diagnosis and treatment. Pathogens. 2021, 10:323. 10.3390\/pathogens10030323","journal-title":"Pathogens"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/odjo.odjo_18_24","article-title":"Acanthamoeba keratitis: A review of risk factors, clinical presentation, and treatment modalities","volume":"31","author":"Gurnani B","year":"2024","unstructured":"Gurnani B, Kaur K, Kaur RP, Aggarwal P, Singh SP. Acanthamoeba keratitis: A review of risk factors, clinical presentation, and treatment modalities. Odisha J Ophthalmol. 2024, 31:11-27. 10.4103\/odjo.odjo_18_24","journal-title":"Odisha J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14072528","article-title":"Acanthamoeba keratitis management and prognostic factors: A systematic review","volume":"14","author":"Marques-Couto P","year":"2025","unstructured":"Marques-Couto P, Monteiro M, Ferreira AM, Pinheiro-Costa J, Vilares-Morgado R. Acanthamoeba keratitis management and prognostic factors: A systematic review. J Clin Med. 2025, 14:2528. 10.3390\/jcm14072528","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/reports8020044","article-title":"Successful treatment of Acanthamoeba keratitis according to new protocol with polihexanide 0.08% therapy: Case report","volume":"8","author":"Kuzman T","year":"2025","unstructured":"Kuzman T, Mati\u0107 S, Gabri\u0107 I, Geber A, Meter A. Successful treatment of Acanthamoeba keratitis according to new protocol with polihexanide 0.08% therapy: Case report. Reports (MDPI). 2025, 8:44. 10.3390\/reports8020044","journal-title":"Reports (MDPI)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.05.012","article-title":"Update on the management of infectious keratitis","volume":"124","author":"Austin A","year":"2017","unstructured":"Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017, 124:1678-89. 10.1016\/j.ophtha.2017.05.012","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.17925\/usor.2022.16.2.72","article-title":"An update on advances in diagnosis and treatment of Acanthamoeba keratitis","volume":"16","author":"Tian J","year":"2022","unstructured":"Tian J, Peralta E, Houser K. An update on advances in diagnosis and treatment of Acanthamoeba keratitis. US Ophthalmic Rev. 2022, 16:72-5. 10.17925\/usor.2022.16.2.72","journal-title":"US Ophthalmic Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.51329\/mehdiophthal1528","article-title":"Acanthamoeba keratitis: From pathophysiology to prevention, a contemporary clinical perspective","volume":"14","author":"Kiyat P","year":"2025","unstructured":"Kiyat P, Palamar M. Acanthamoeba keratitis: From pathophysiology to prevention, a contemporary clinical perspective. Med Hypothesis Discov Innov Ophthalmol. 2025, 14:146-62. 10.51329\/mehdiophthal1528","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000804","article-title":"Update on Acanthamoeba keratitis: Diagnosis, treatment, and outcomes","volume":"35","author":"Maycock NJ","year":"2016","unstructured":"Maycock NJ, Jayaswal R. Update on Acanthamoeba keratitis: Diagnosis, treatment, and outcomes. Cornea. 2016, 35:713-20. 10.1097\/ICO.0000000000000804","journal-title":"Cornea"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1147077","article-title":"Biological characteristics and pathogenicity of Acanthamoeba","volume":"14","author":"Wang Y","year":"2023","unstructured":"Wang Y, Jiang L, Zhao Y, et al.. Biological characteristics and pathogenicity of Acanthamoeba. Front Microbiol. 2023, 14:1147077. 10.3389\/fmicb.2023.1147077","journal-title":"Front Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2024-002082","article-title":"Polihexanide (PHMB) 0.08% versus currently used treatments for Acanthamoeba keratitis: Indirect treatment comparisons","volume":"10","author":"Papa V","year":"2025","unstructured":"Papa V, Galeone C, De Francesco M, et al.. Polihexanide (PHMB) 0.08% versus currently used treatments for Acanthamoeba keratitis: Indirect treatment comparisons. BMJ Open Ophthalmol. 2025, 10:e002082. 10.1136\/bmjophth-2024-002082","journal-title":"BMJ Open Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.09.031","article-title":"The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (polihexanide) and placebo versus PHMB 0.02% and propamidine 0.1","volume":"131","author":"Dart JK","year":"2024","unstructured":"Dart JK, Papa V, Rama P, et al.. The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (polihexanide) and placebo versus PHMB 0.02% and propamidine 0.1. Ophthalmology. 2024, 131:277-87. 10.1016\/j.ophtha.2023.09.031","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/11206721251407855","article-title":"Efficacy and safety of polyhexamethylene biguanide for Acanthamoeba keratitis: Systematic review and proportional meta-analysis","author":"Singh M","year":"2025","unstructured":"Singh M, Husain N, Dutta S, Sinha BP, Mohan L, Dikshit H, Sharma B. Efficacy and safety of polyhexamethylene biguanide for Acanthamoeba keratitis: Systematic review and proportional meta-analysis. Eur J Ophthalmol. 2025, 11206721251407855. 10.1177\/11206721251407855","journal-title":"Eur J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000001092","article-title":"Novel effective medical therapy for Acanthamoeba keratitis","volume":"50","author":"Di Zazzo A","year":"2024","unstructured":"Di Zazzo A, De Gregorio C, Coassin M. Novel effective medical therapy for Acanthamoeba keratitis. Eye Contact Lens. 2024, 50:279-81. 10.1097\/ICL.0000000000001092","journal-title":"Eye Contact Lens"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13162655","article-title":"Diagnosis of Acanthamoeba keratitis: Past, present and future","volume":"13","author":"Azzopardi M","year":"2023","unstructured":"Azzopardi M, Chong YJ, Ng B, Recchioni A, Logeswaran A, Ting DS. Diagnosis of Acanthamoeba keratitis: Past, present and future. Diagnostics (Basel). 2023, 13:2655. 10.3390\/diagnostics13162655","journal-title":"Diagnostics (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-003-0805-7","article-title":"Delay in diagnosis and outcome of Acanthamoeba keratitis","volume":"242","author":"Claerhout I","year":"2004","unstructured":"Claerhout I, Goegebuer A, Van Den Broecke C, Kestelyn P. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol. 2004, 242:648-53. 10.1007\/s00417-003-0805-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1559224","article-title":"The pathogenesis, risk factors, diagnosis and treatment of Acanthamoeba keratitis","volume":"12","author":"Bao M","year":"2025","unstructured":"Bao M, Bao H, Wang S, Zhou H. The pathogenesis, risk factors, diagnosis and treatment of Acanthamoeba keratitis. Front Med (Lausanne). 2025, 12:1559224. 10.3389\/fmed.2025.1559224","journal-title":"Front Med (Lausanne)"},{"key":"ref20","article-title":"Early diagnosis of infectious keratitis with in vivo real time confocal microscopy","volume":"18","author":"Chew SJ","year":"1992","unstructured":"Chew SJ, Beuerman RW, Assouline M, Kaufman HE, Barron BA, Hill JM. Early diagnosis of infectious keratitis with in vivo real time confocal microscopy. CLAO J. 1992, 18:197-201.","journal-title":"CLAO J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.08.037","article-title":"Assessment of confocal microscopy for the diagnosis of polymerase chain reaction-positive Acanthamoeba keratitis: A case-control study","volume":"125","author":"De Craene S","year":"2018","unstructured":"De Craene S, Knoeri J, Georgeon C, Kestelyn P, Borderie VM. Assessment of confocal microscopy for the diagnosis of polymerase chain reaction-positive Acanthamoeba keratitis: A case-control study. Ophthalmology. 2018, 125:161-8. 10.1016\/j.ophtha.2017.08.037","journal-title":"Ophthalmology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10050942","article-title":"Challenges in Acanthamoeba keratitis: A review","volume":"10","author":"Varacalli G","year":"2021","unstructured":"Varacalli G, Di Zazzo A, Mori T, Dohlman TH, Spelta S, Coassin M, Bonini S. Challenges in Acanthamoeba keratitis: A review. J Clin Med. 2021, 10:942. 10.3390\/jcm10050942","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S519705","article-title":"In vivo confocal microscopy for corneal and ocular surface pathologies: A comprehensive review","volume":"19","author":"Ramirez-Miranda A","year":"2025","unstructured":"Ramirez-Miranda A, Guerrero-Becerril J, Ramirez M, et al.. In vivo confocal microscopy for corneal and ocular surface pathologies: A comprehensive review. Clin Ophthalmol. 2025, 19:1817-34. 10.2147\/OPTH.S519705","journal-title":"Clin Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1924673","article-title":"Acanthamoeba keratitis: An update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs","volume":"19","author":"Shing B","year":"2021","unstructured":"Shing B, Balen M, McKerrow JH, Debnath A. Acanthamoeba keratitis: An update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs. Expert Rev Anti Infect Ther. 2021, 19:1427-41. 10.1080\/14787210.2021.1924673","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2025.03.008","article-title":"Acanthamoeba keratitis treatment outcomes compared for drug delivery by protocol versus physician's individualised treatment","volume":"38","author":"Dart JK","year":"2025","unstructured":"Dart JK, Papa V, Rama P, et al.. Acanthamoeba keratitis treatment outcomes compared for drug delivery by protocol versus physician's individualised treatment. Ocul Surf. 2025, 38:132-41. 10.1016\/j.jtos.2025.03.008","journal-title":"Ocul Surf"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1159\/000533988","article-title":"Use of amniotic membrane transplant and deep anterior keratoplasty in a patient with bilateral Acanthamoeba infectious keratitis: A case report","volume":"14","author":"M\u00fcller-Morales CA","year":"2023","unstructured":"M\u00fcller-Morales CA, Vera-Duarte GR, Oliva-Bienzobas V, Ramirez-Miranda A, Navas A, Graue-Hernandez EO. Use of amniotic membrane transplant and deep anterior keratoplasty in a patient with bilateral Acanthamoeba infectious keratitis: A case report. Case Rep Ophthalmol. 2023, 14:568-75. 10.1159\/000533988","journal-title":"Case Rep Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00309-10","article-title":"Resistance of Acanthamoeba cysts to disinfection treatments used in health care settings","volume":"48","author":"Coulon C","year":"2010","unstructured":"Coulon C, Collignon A, McDonnell G, Thomas V. Resistance of Acanthamoeba cysts to disinfection treatments used in health care settings. J Clin Microbiol. 2010, 48:2689-97. 10.1128\/JCM.00309-10","journal-title":"J Clin Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1089092","article-title":"Acanthamoeba spp. aggregate and encyst on contact lens material increasing resistance to disinfection","volume":"13","author":"Campolo A","year":"2022","unstructured":"Campolo A, Pifer R, Walters R, et al.. Acanthamoeba spp. aggregate and encyst on contact lens material increasing resistance to disinfection. Front Microbiol. 2022, 13:1089092. 10.3389\/fmicb.2022.1089092","journal-title":"Front Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317848","article-title":"Safety and tolerability of topical polyhexamethylene biguanide: A randomised clinical trial in healthy adult volunteers","volume":"106","author":"Papa V","year":"2022","unstructured":"Papa V, van der Meulen I, Rottey S, et al.. Safety and tolerability of topical polyhexamethylene biguanide: A randomised clinical trial in healthy adult volunteers. Br J Ophthalmol. 2022, 106:190-6. 10.1136\/bjophthalmol-2020-317848","journal-title":"Br J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462123-successful-treatment-of-acanthamoeba-keratitis-using-008-polyhexamethylene-biguanide-monotherapy-a-report-of-a-case-in-latin-america","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:42:56Z","timestamp":1771558976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462123-successful-treatment-of-acanthamoeba-keratitis-using-008-polyhexamethylene-biguanide-monotherapy-a-report-of-a-case-in-latin-america"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.103935","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,19]]}}}